Physician profile
Meredith D Kapner
NPI 1568806230
$1,969.31
in general payments reported to CMS, 2019-2025
24 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $152 · 2021: $321 · 2022: $388 · 2023: $307 · 2024: $312 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $466.52 | 2019-2024 | |
| Pfizer INC. | $192.73 | 2019-2025 | |
| Aspira Women'S Health INC | $181.12 | 2022 | |
| Exeltis, USA INC. | $177.39 | 2019-2024 | Slynd |
| Daiichi Sankyo INC. | $132.23 | 2019-2021 | |
| Astellas Pharma US INC | $101.98 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $79.59 | 2019-2023 | Mara Console, Summit Doppler |
| Renovia INC | $72.98 | 2021 | |
| Amgen INC. | $68.60 | 2020-2024 | Evenity, Prolia |
| Medtronic, INC. | $64.19 | 2024 | V-Loc 180 |
| Bayer Healthcare Pharmaceuticals INC. | $63.26 | 2019-2022 | |
| Therapeuticsmd, INC. | $57.23 | 2019-2022 | |
| Sage Therapeutics, LLC | $48.22 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $42.60 | 2019 | |
| Mylan Pharmaceuticals INC. | $40.20 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $29.08 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $27.49 | 2024 | Myfembree |
| Millicent US INC | $23.62 | 2024 | Femring, Intrarosa |
| Scynexis, INC. | $19.83 | 2022 | |
| Hologic Sales and Service, LLC | $18.38 | 2025 | Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $17.67 | 2019 | |
| Myovant Sciences INC. | $16.18 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.03 | 2025 | Qelbree |
| Channel Medsystems, INC. | $13.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Kapner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.